214 related articles for article (PubMed ID: 32771029)
1. Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation.
Gernert M; Tony HP; Schwaneck EC; Fröhlich M; Schmalzing M
Arthritis Res Ther; 2020 Aug; 22(1):183. PubMed ID: 32771029
[TBL] [Abstract][Full Text] [Related]
2. Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Schmalzing M
Arthritis Res Ther; 2019 Apr; 21(1):106. PubMed ID: 31036055
[TBL] [Abstract][Full Text] [Related]
3. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients.
Lima-Júnior JR; Arruda LCM; Gonçalves MS; Dias JBE; Moraes DA; Covas DT; Simões BP; Oliveira MC; Malmegrim KCR
Rheumatology (Oxford); 2021 Dec; 60(12):5538-5548. PubMed ID: 33724344
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
Front Immunol; 2021; 12():817893. PubMed ID: 35111167
[TBL] [Abstract][Full Text] [Related]
5. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome.
Pecher AC; Klein R; Koetter I; Wagner M; Vogel W; Wirths S; Lengerke C; Henes JC
Arthritis Res Ther; 2024 Mar; 26(1):75. PubMed ID: 38509633
[TBL] [Abstract][Full Text] [Related]
6. Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases.
Szodoray P; Varoczy L; Papp G; Barath S; Nakken B; Szegedi G; Zeher M
Scand J Rheumatol; 2012 Mar; 41(2):110-5. PubMed ID: 21936606
[TBL] [Abstract][Full Text] [Related]
7. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.
Arruda LCM; Malmegrim KCR; Lima-Júnior JR; Clave E; Dias JBE; Moraes DA; Douay C; Fournier I; Moins-Teisserenc H; Alberdi AJ; Covas DT; Simões BP; Lansiaux P; Toubert A; Oliveira MC
Blood Adv; 2018 Jan; 2(2):126-141. PubMed ID: 29365321
[TBL] [Abstract][Full Text] [Related]
8. Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.
Farge D; Arruda LC; Brigant F; Clave E; Douay C; Marjanovic Z; Deligny C; Maki G; Gluckman E; Toubert A; Moins-Teisserenc H
J Hematol Oncol; 2017 Jan; 10(1):21. PubMed ID: 28103947
[TBL] [Abstract][Full Text] [Related]
9. Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis.
Boukouaci W; Lansiaux P; Lambert NC; Picard C; Clave E; Cras A; Marjanovic Z; Farge D; Tamouza R
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806227
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Ruder J; Dinner G; Maceski A; Berenjeno-Correa E; Müller AM; Jelcic I; Kuhle J; Martin R
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142860
[TBL] [Abstract][Full Text] [Related]
11. Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis.
Helbig G; Widuchowska M; Koclęga A; Kopińska A; Kopeć-Mędrek M; Gaweł WB; Spałek A; Żak J; Grygoruk-Wiśniowska I; Liwoch R; Kucharz E; Markiewicz M
Clin Rheumatol; 2018 Jun; 37(6):1709-1714. PubMed ID: 29256111
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
[TBL] [Abstract][Full Text] [Related]
13. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
Front Immunol; 2018; 9():2390. PubMed ID: 30386340
[TBL] [Abstract][Full Text] [Related]
14. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.
Arruda LCM; de Azevedo JTC; de Oliveira GLV; Scortegagna GT; Rodrigues ES; Palma PVB; Brum DG; Guerreiro CT; Marques VD; Barreira AA; Covas DT; Simões BP; Voltarelli JC; Oliveira MC; Malmegrim KCR
Clin Immunol; 2016 Aug; 169():47-57. PubMed ID: 27318116
[TBL] [Abstract][Full Text] [Related]
15. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
Vaivade A; Wiberg A; Khoonsari PE; Carlsson H; Herman S; Al-Grety A; Freyhult E; Olsson-Strömberg U; Burman J; Kultima K
Lipids Health Dis; 2023 Jul; 22(1):97. PubMed ID: 37420217
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication.
Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Fröhlich M; Portegys J; Strunz PP; Schmalzing M
Rheumatol Int; 2022 Aug; 42(8):1373-1381. PubMed ID: 34694439
[TBL] [Abstract][Full Text] [Related]
17. Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.
Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J
Cytotherapy; 2023 Dec; 25(12):1271-1276. PubMed ID: 37737765
[TBL] [Abstract][Full Text] [Related]
18. Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis.
Simon D; Balogh P; Bognár A; Kellermayer Z; Engelmann P; Németh P; Farkas N; Minier T; Lóránd V; Czirják L; Berki T
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):30-36. PubMed ID: 27056741
[TBL] [Abstract][Full Text] [Related]
19. Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients.
Strunz PP; Froehlich M; Gernert M; Schwaneck EC; Fleischer A; Pecher AC; Tony HP; Henes JC; Schmalzing M
Front Immunol; 2021; 12():723349. PubMed ID: 34539659
[TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
